▶ 調査レポート

抗ウイルス薬のグローバル市場

• 英文タイトル:Global Market Study on Antiviral Drugs: Swelled demand for broad-spectrum antibiotic drugs to amplify the market

Global Market Study on Antiviral Drugs: Swelled demand for broad-spectrum antibiotic drugs to amplify the market「抗ウイルス薬のグローバル市場」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2304I0156
• 出版社/出版日:Persistence Market Research / 2023年1月10日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Site Licence¥1,140,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,590,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、世界の抗ウイルス薬市場にフォーカスし、最新動向と今後の市場性について分析しています。本書は、エグゼクティブサマリー、市場概要、市場リスク・動向評価、市場背景、主要成功要因、需要分析・予測、価値分析・予測、薬剤クラス別(DNAポリメラーゼ阻害剤、逆転写酵素阻害剤、ノイラミニダーゼ阻害剤、プロテアーゼ阻害剤、その他)分析、種類別(ブランド、ジェネリック)分析、用途別(HIV、肝炎、ヘルペス、インフルエンザ、その他)分析、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ)分析、市場構造分析、競争分析、仮定、調査手法などの情報を整理しています。また、Gilead Sciences Inc、GlaxoSmithKline plc、F. Hoffmann-La Roche Ltd、Merck & Co. Inc、AbbVie、Johnson & Johnson Services, Inc.、Bristol-Myers Squibb Company、Cipla Inc.、Aurobindo Pharma、Dr. Reddy’s Laboratories Ltd.など、主要企業情報が含まれています。

・エグゼクティブサマリー
・市場概要
・市場リスク・動向評価
・市場背景
・主要成功要因
・需要分析・予測
・価値分析・予測
・世界の抗ウイルス薬市場規模:薬剤クラス別
- DNAポリメラーゼ阻害剤の市場規模
- 逆転写酵素阻害剤の市場規模
- ノイラミニダーゼ阻害剤の市場規模
- プロテアーゼ阻害の市場規模
- その他薬剤クラスの市場規模
・世界の抗ウイルス薬市場規模:種類別
- ブランドにおける市場規模
- ジェネリックにおける市場規模
・世界の抗ウイルス薬市場規模:用途別
- HIVにおける市場規模
- 肝炎における市場規模
- ヘルペスにおける市場規模
- インフルエンザにおける市場規模
- その他用途における市場規模
・世界の抗ウイルス薬市場規模:地域別
- 北米の抗ウイルス薬市場規模
- 中南米の抗ウイルス薬市場規模
- ヨーロッパの抗ウイルス薬市場規模
- アジア太平洋の抗ウイルス薬市場規模
- 中東・アフリカの抗ウイルス薬市場規模
・市場構造分析
・競争分析
・仮定
・調査手法

Global Antiviral Drugs Market – Scope of Report

A recent study by Persistence Market Research on the?Global Antiviral Drugs market offers a 10-year forecast for 2022 to 2032. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering?Global Antiviral Drugs products

The study also provides the dynamics responsible for influencing the future status of the?Global Antiviral Drugs market over the forecast period. A detailed assessment of value chain analysis, business execution, and segment wise analysis across regional markets has been covered in the report.

A list of prominent companies operating in the?Global Antiviral Drugs market, along with their product portfolios, key strategies and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of?Global Antiviral Drugs across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the product and services of Global Antiviral Drugs during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of value (US$ Mn).

Estimates at global and regional levels for?Global Antiviral Drugs and the Global Antiviral Drugs market are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar?opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and services perspective in the global?Antiviral Drugs market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the?Global Antiviral Drugs market during the forecast period.

Country-specific valuation on demand for?Global Antiviral Drugs has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading players of?Global Antiviral Drugs markets along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering?Global Antiviral Drugs has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the Global Antiviral Drugs Market.

レポート目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Persistence Market Research Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact on Antiviral Drugs

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Million)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Antiviral Drugs Market, by Key Countries

    4.2. Antiviral Drugs Market Opportunity Assessment (US$ Million)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors – Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Patch Management Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Patch Management Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Antiviral Drugs Market Demand Analysis 2018-2022 and Forecast, 2023-2033

    6.1. Historical Market Analysis, 2018-2022

    6.2. Current and Future Market Projections, 2023-2033

    6.3. Y-o-Y Growth Trend Analysis

7. Global Antiviral Drugs Market Value Analysis 2018-2022 and Forecast, 2023-2033

    7.1. Historical Market Value (US$ Million) Analysis, 2018-2022

    7.2. Current and Future Market Value (US$ Million) Projections, 2023-2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Class

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Million) Analysis By Drug Class, 2018-2022

    8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Drug Class, 2023-2033

        8.3.1. DNA Polymerase Inhibitors

        8.3.2. Reverse Transcriptase Inhibitors

        8.3.3. Neuraminidase Inhibitors

        8.3.4. Protease Inhibitors

        8.3.5. others

    8.4. Market Attractiveness Analysis By Drug Class

9. Global Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033, By Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Million) Analysis By Type, 2018-2022

    9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type, 2023-2033

        9.3.1. Branded

        9.3.2. Generics

    9.4. Market Attractiveness Analysis By Type

10. Global Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) Analysis By Application, 2018-2022

    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023-2033

        10.3.1. HIV

        10.3.2. Hepatitis

        10.3.3. Herpes

        10.3.4. Influenza

        10.3.5. Other Applications

    10.4. Market Attractiveness Analysis By Application

11. Global Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Million) Analysis By Region, 2018-2022

    11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023-2033

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023-2033

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Drug Class

        12.4.3. By Application

        12.4.4. By Type

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Drug Class

        12.5.3. By Application

        12.5.4. By Type

13. Latin America Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023-2033

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Drug Class

        13.4.3. By Application

        13.4.4. By Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Drug Class

        13.5.3. By Application

        13.5.4. By Type

14. Europe Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023-2033

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. U.K.

            14.4.1.4. Italy

            14.4.1.5. Spain

            14.4.1.6. Russia

            14.4.1.7. Rest of Europe

        14.4.2. By Drug Class

        14.4.3. By Application

        14.4.4. By Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Drug Class

        14.5.3. By Application

        14.5.4. By Type

15. Asia Pacific Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023-2033

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Australia

            15.4.1.5. India

            15.4.1.6. Rest of Asia Pacific

        15.4.2. By Drug Class

        15.4.3. By Application

        15.4.4. By Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Drug Class

        15.5.3. By Application

        15.5.4. By Type

16. Middle East and Africa Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022

    16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023-2033

        16.4.1. By Country

            16.4.1.1. Saudi Arabia

            16.4.1.2. South Africa

            16.4.1.3. Israel

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Drug Class

        16.4.3. By Application

        16.4.4. By Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Drug Class

        16.5.3. By Application

        16.5.4. By Type

17. Key Countries Antiviral Drugs Market Analysis 2018-2022 and Forecast 2023-2033

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. US Antiviral Drugs Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.2.2.1. By Drug Class

            17.2.2.2. By Application

            17.2.2.3. By Type

    17.3. Canada Antiviral Drugs Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.3.2.1. By Drug Class

            17.3.2.2. By Application

            17.3.2.3. By Type

    17.4. Mexico Antiviral Drugs Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.4.2.1. By Drug Class

            17.4.2.2. By Application

            17.4.2.3. By Type

    17.5. Brazil Antiviral Drugs Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.5.2.1. By Drug Class

            17.5.2.2. By Application

            17.5.2.3. By Type

    17.6. Germany Antiviral Drugs Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.6.2.1. By Drug Class

            17.6.2.2. By Application

            17.6.2.3. By Type

    17.7. France Antiviral Drugs Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.7.2.1. By Drug Class

            17.7.2.2. By Application

            17.7.2.3. By Type

    17.8. Italy Antiviral Drugs Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.8.2.1. By Drug Class

            17.8.2.2. By Application

            17.8.2.3. By Type

    17.9. Spain Antiviral Drugs Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.9.2.1. By Drug Class

            17.9.2.2. By Application

            17.9.2.3. By Type

    17.10. UK Antiviral Drugs Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.10.2.1. By Drug Class

            17.10.2.2. By Application

            17.10.2.3. By Type

    17.11. Russia Antiviral Drugs Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.11.2.1. By Drug Class

            17.11.2.2. By Application

            17.11.2.3. By Type

    17.12. China Antiviral Drugs Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.12.2.1. By Drug Class

            17.12.2.2. By Application

            17.12.2.3. By Type

    17.13. Japan Antiviral Drugs Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.13.2.1. By Drug Class

            17.13.2.2. By Application

            17.13.2.3. By Type

    17.14. South Korea Antiviral Drugs Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.14.2.1. By Drug Class

            17.14.2.2. By Application

            17.14.2.3. By Type

    17.15. Saudi Arabia Antiviral Drugs Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.15.2.1. By Drug Class

            17.15.2.2. By Application

            17.15.2.3. By Type

    17.16. South Africa Antiviral Drugs Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.16.2.1. By Drug Class

            17.16.2.2. By Application

            17.16.2.3. By Type

    17.17. Israel Antiviral Drugs Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033

            17.17.2.1. By Drug Class

            17.17.2.2. By Application

            17.17.2.3. By Type

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Gilead Sciences Inc

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. GlaxoSmithKline plc

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. F. Hoffmann-La Roche Ltd

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Merck & Co. Inc

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. AbbVie

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Johnson & Johnson Services, Inc.

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Bristol-Myers Squibb Company

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Cipla Inc.

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Aurobindo Pharma

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. Dr. Reddy’s Laboratories Ltd.

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Table 1: Global Antiviral Drugs Market Value (US$ Million), By Drug Class, 2018 – 2022

Table 2: Global Antiviral Drugs Market Value (US$ Million), By Drug Class, 2023 – 2033

Table 3: Global Antiviral Drugs Market Value (US$ Million), By Application, 2018 – 2022

Table 4: Global Antiviral Drugs Market Value (US$ Million), By Application, 2023 – 2033

Table 5: Global Antiviral Drugs Market Value (US$ Million), By Type, 2018 – 2022

Table 6: Global Antiviral Drugs Market Value (US$ Million), By Type, 2023 – 2033

Table 7: Global Antiviral Drugs Market, By Region, 2018 – 2022

Table 8: Global Antiviral Drugs Market, By Region, 2023 – 2033

Table 9: North America Antiviral Drugs Market Value (US$ Million), By Drug Class, 2018 – 2022

Table 10: North America Antiviral Drugs Market Value (US$ Million), By Drug Class, 2023 – 2033

Table 11: North America Antiviral Drugs Market Value (US$ Million), By Application, 2018 – 2022

Table 12: North America Antiviral Drugs Market Value (US$ Million), By Application, 2023 – 2033

Table 13: North America Antiviral Drugs Market Value (US$ Million), By Type, 2018 – 2022

Table 14: North America Antiviral Drugs Market Value (US$ Million), By Type, 2023 – 2033

Table 15: North America Antiviral Drugs Market, By Country, 2018 – 2022

Table 16: North America Antiviral Drugs Market, By Country, 2023 – 2033

Table 17: Latin America Antiviral Drugs Market Value (US$ Million), By Drug Class, 2018 – 2022

Table 18: Latin America Antiviral Drugs Market Value (US$ Million), By Drug Class, 2023 – 2033

Table 19: Latin America Antiviral Drugs Market Value (US$ Million), By Application, 2018 – 2022

Table 20: Latin America Antiviral Drugs Market Value (US$ Million), By Application, 2023 – 2033

Table 21: Latin America Antiviral Drugs Market Value (US$ Million), By Type, 2018 – 2022

Table 22: Latin America Antiviral Drugs Market Value (US$ Million), By Type, 2023 – 2033

Table 23: Latin America Antiviral Drugs Market, By Country, 2018 – 2022

Table 24: Latin America Antiviral Drugs Market, By Country, 2023 – 2033

Table 25: Europe Antiviral Drugs Market Value (US$ Million), By Drug Class, 2018 – 2022

Table 26: Europe Antiviral Drugs Market Value (US$ Million), By Drug Class, 2023 – 2033

Table 27: Europe Antiviral Drugs Market Value (US$ Million), By Application, 2018 – 2022

Table 28: Europe Antiviral Drugs Market Value (US$ Million), By Application, 2023 – 2033

Table 29: Europe Antiviral Drugs Market Value (US$ Million), By Type, 2018 – 2022

Table 30: Europe Antiviral Drugs Market Value (US$ Million), By Type, 2023 – 2033

Table 31: Europe Antiviral Drugs Market, By Country, 2018 – 2022

Table 32: Europe Antiviral Drugs Market, By Country, 2023 – 2033

Table 33: Asia Pacific Antiviral Drugs Market Value (US$ Million), By Drug Class, 2018 – 2022

Table 34: Asia Pacific Antiviral Drugs Market Value (US$ Million), By Drug Class, 2023 – 2033

Table 35: Asia Pacific Antiviral Drugs Market Value (US$ Million), By Application, 2018 – 2022

Table 36: Asia Pacific Antiviral Drugs Market Value (US$ Million), By Application, 2023 – 2033

Table 37: Asia Pacific Antiviral Drugs Market Value (US$ Million), By Type, 2018 – 2022

Table 38: Asia Pacific Antiviral Drugs Market Value (US$ Million), By Type, 2023 – 2033

Table 39: Asia Pacific Antiviral Drugs Market, By Country, 2018 – 2022

Table 40: Asia Pacific Antiviral Drugs Market, By Country, 2023 – 2033

Table 41: MEA Antiviral Drugs Market Value (US$ Million), By Drug Class, 2018 – 2022

Table 42: MEA Antiviral Drugs Market Value (US$ Million), By Drug Class, 2023 – 2033

Table 43: MEA Antiviral Drugs Market Value (US$ Million), By Application, 2018 – 2022

Table 44: MEA Antiviral Drugs Market Value (US$ Million), By Application, 2023 – 2033

Table 45: MEA Antiviral Drugs Market Value (US$ Million), By Type, 2018 – 2022

Table 46: MEA Antiviral Drugs Market Value (US$ Million), By Type, 2023 – 2033

Table 47: MEA Antiviral Drugs Market, By Country, 2018 – 2022

Table 48: MEA Antiviral Drugs Market, By Country, 2023 – 2033

Table 49: Global Antiviral Drugs Market Incremental $ Opportunity, By Drug Class, 2018 - 2022

Table 50: Global Antiviral Drugs Market Incremental $ Opportunity, By Application, 2023 – 2033

Table 51: Global Antiviral Drugs Market Incremental $ Opportunity, By Type, 2018 - 2022

Table 52: Global Antiviral Drugs Market Incremental $ Opportunity, By Region, 2023 – 2033

Table 53: North America Antiviral Drugs Market Incremental $ Opportunity, By Drug Class, 2018 - 2022

Table 54: North America Antiviral Drugs Market Incremental $ Opportunity, By Application, 2023 – 2033

Table 55: North America Antiviral Drugs Market Incremental $ Opportunity, By Type, 2018 – 2022

Table 56: North America Antiviral Drugs Market Incremental $ Opportunity, By Country, 2023 – 2033

Table 57: Latin America Antiviral Drugs Market Incremental $ Opportunity, By Drug Class, 2018 - 2022

Table 58: Latin America Antiviral Drugs Market Incremental $ Opportunity, By Application, 2023 – 2033

Table 59: Latin America Antiviral Drugs Market Incremental $ Opportunity, By Type, 2018 - 2022

Table 60: Latin America Antiviral Drugs Market Incremental $ Opportunity, By Country, 2023 – 2033

Table 61: Europe Antiviral Drugs Market Incremental $ Opportunity, By Drug Class, 2018 - 2022

Table 62: Europe Antiviral Drugs Market Incremental $ Opportunity, By Application, 2023 – 2033

Table 63: Europe Antiviral Drugs Market Incremental $ Opportunity, By Type, 2018 - 2022

Table 64: Europe Antiviral Drugs Market Incremental $ Opportunity, By Country, 2023 - 2033

Table 65: Asia Pacific Antiviral Drugs Market Incremental $ Opportunity, By Drug Class, 2018 - 2022

Table 66: Asia Pacific Antiviral Drugs Market Incremental $ Opportunity, By Application, 2023 – 2033

Table 67: Asia Pacific Antiviral Drugs Market Incremental $ Opportunity, By Type, 2018 - 2022

Table 68: Asia Pacific Antiviral Drugs Market Incremental $ Opportunity, By Country, 2023 – 2033

Table 69: MEA Antiviral Drugs Market Incremental $ Opportunity, By Drug Class, 2018 - 2022

Table 70: MEA Antiviral Drugs Market Incremental $ Opportunity, By Application, 2023 – 2033

Table 71: MEA Antiviral Drugs Market Incremental $ Opportunity, By Type, 2018 - 2022

Table 72: MEA Antiviral Drugs Market Incremental $ Opportunity, By Country, 2023 - 2033